Volume 20, Issue 1 (Spring 2014)                   IJPCP 2014, 20(1): 29-34 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Jahanian A A, Rezaei O, Fadai F, Yaraghchi A. The Effectiveness of Rivastigmine in Reducing Tardive Dyskinesia Symptoms in Patients with Schizophrenia . IJPCP 2014; 20 (1) :29-34
URL: http://ijpcp.iums.ac.ir/article-1-2143-en.html
1- University of Social Wafer and Rehabilitation Sciences, Tehran, Iran
2- University of Social Wafer and Rehabilitation Sciences, Tehran, Iran, IR. , E-mail:dr.rezaei@uswr.ac.ir
3- Islamic Azad University, Science and Research Branch, Tehran, Iran.
Abstract:   (8952 Views)

  Objectives : The aim of this study was to examine the effectiveness of rivastigmine on reducing tardive dyskinesia (TD) symptoms in patients with schizophrenia receiving antipsychotic treatment. Method: Forty male patients with schizophrenia and tardive dyskinesia symptoms [based on the Diagnostic and Statistical Manual of Mental Disorders, 4th. ed., Text Revision (DSM- IV-TR) criteria] hospitalized in Razi Psychiatric Hospital with a stable mental status within a month prior to the study were selected using convenience sampling. The subjects were randomly divided into two groups each with 20 individuals one group received placebo and the other rivastigmine. At the beginning of the study and after eight weeks, severity of symptoms of TD was assessed by Abnormal Involuntary Movement Scale (AIMS). Data analysis was done by analysis of covariance. Results: There were significant difference between posttest mean scores of the two groups (p<0.05). Conclusions: Rivastigmine is effective in reducing TD symptoms in patients with schizophrenia .

Full-Text [PDF 149 kb]   (2922 Downloads)    
Type of Study: Original Research | Subject: Psychiatry and Psychology
Received: 2014/07/27 | Accepted: 2014/07/27 | Published: 2014/07/27

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Psychiatry and Clinical Psychology

Designed & Developed by : Yektaweb